mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.4 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |